Syngene International Limited carries a market capitalization of 174.98B, placing it among publicly traded companies globally. Its enterprise value stands at 256.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 174.98B |
| Enterprise Value | 256.53B |
Syngene International Limited trades at a trailing price-to-earnings ratio of 50.58.
| PE Ratio | 50.58 |
| PS Ratio | 6.88 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Syngene International Limited trades at an EV/EBITDA multiple of 39.78 and an EV/FCF ratio of 629.73. The EV/Sales ratio of 6.88 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 39.78 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.88 |
| EV / EBITDA | 39.78 |
| EV / EBIT | 39.78 |
| EV / FCF | 629.73 |
Syngene International Limited maintains a current ratio of 3.63, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 26.71, indicating elevated leverage, while an interest coverage ratio of 12.17 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.63 |
| Quick Ratio | 2.11 |
| Debt / Equity | 26.71 |
| Debt / EBITDA | N/A |
| Interest Coverage | 12.17 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 54.20 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Syngene International Limited has paid 1.53B in income taxes, reflecting an effective tax rate of 23.14.
| Income Tax | 1.53B |
| Effective Tax Rate | 23.14 |
Syngene International Limited's stock has declined approximately -31.8921% over the past 52 weeks. The 50-day moving average sits at 435.57, while the 200-day moving average is 547.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -31.8921% |
| 50-Day Moving Average | 435.57 |
| 200-Day Moving Average | 547.20 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Syngene International Limited generated 37.27B in revenue and converted that into 5.07B in net income, yielding earnings per share of 12.61. EBITDA reached 6.45B, while operating income came in at 6.45B.
| Revenue | 37.27B |
| Gross Profit | 28.01B |
| Operating Income | 6.45B |
| Pretax Income | 6.60B |
| Net Income | 5.07B |
| EBITDA | 6.45B |
| EBIT | 6.45B |
| Earnings Per Share (EPS) | 12.61 |
Syngene International Limited operates with a gross margin of 75.14, reflecting its pricing power and cost economics. The operating margin of 17.30 and net profit margin of 13.61 provide insight into operational efficiency.
| Gross Margin | 75.14 |
| Operating Margin | 17.30 |
| Pretax Margin | 17.70 |
| Profit Margin | 13.61 |
| EBITDA Margin | 17.30 |
Syngene International Limited's most recent stock split took place on June 11, 2019 with a 1:2 split ratio.
| Last Split Date | 6/11/2019 |
| Split Ratio | 1:2 |
Syngene International Limited posts an Altman Z-Score of 23.74, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 23.74 |